Digital Frontiers Health at 10: Future health, cost, and collaborati... Frontiers Health is all about global innovation, the future of health unfolding by grace of science across the world.
Digital AI doesn’t have to be 100% reliable to be useful Generative AI models aren’t perfect. They hallucinate and make mistakes. But that doesn't have to be disqualifying, say AI implementation experts.
Digital FH25: On the future of health, with Frontiers Health Chairma... In the final episode of our special Frontiers Health limited series, conference Chairman Roberto Ascione discusses his favourite moments and insights.
Digital FH25: Jessica DaMassa on hosting, hype, and health innovatio... In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with WTF Health founder and event emcee, Jessica DaMassa
Market Access FH25: Commercialising Health Tech and Deeptech, with Pilar F... In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy expert Pilar Fernández Hermida.
Patients FH25: On patient access and equity, with Roberta Sarno In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.